Verifying…
Home / Drug A–Z / Emtrim Dispersible Tablet

Emtrim Dispersible Tablet

NAFDAC Reg. No. B4-3242 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Emtrim Dispersible Tablet
NAFDAC number
B4-3242
Active ingredient
Sulfamethoxazole; Trimethoprim
Strength
100 mg; 20 mg
Form
Dispersible tablet
Pack size
10 x 10's
Manufacturer
Not listed
Applicant (holder)
Emzor Pharmaceutical Industries Limited
Approved
27 Jun 2024
Status
Active View on NAFDAC ↗
Registration valid to
26 Jun 2029
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Emtrim Dispersible Tablet is on the NAFDAC register with an active registration (B4-3242). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Emtrim Dispersible Tablet

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. …

How to take it and how often
  • Sulfamethoxazole and trimethoprim tablets are contraindicated
  • Pediatric patients less than 2 months of age
  • Urinary Tract Infections and Shigellosis
  • Adults and
  • Pediatric Patients, and Acute Otitis Media in Children
  • Adults: The usual adult dosage in the treatment of urinary tract infections is 1 sulfamethoxazole and trimethoprim DS (double strength) tablet or 2 sulfamethoxazole and trimethoprim tablets every 12 hours for 10 to 14 days
  • An identical daily dosage is used for 5 days in the treatment of shigellosis
  • Children: The recommended dose for children with urinary tract infections or acute otitis media is 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours, given in two divided doses every 12 hours for 10 days
  • An identical daily dosage is used for 5 days in the treatment of shigellosis
  • The following table is a guideline for the attainment of this dosage: Children 2 months of age or older: Weight Dose – every 12 hours lb kg Tablets 22 10 - 44 20 1 66 30 1½ 88 40 2 or 1 DS tablet For Patients with Impaired Renal Function When renal function is impaired, a reduced dosage should be employed using the following table: Creatinine Clearance (mL/min) Recommended Dosage Regimen Above 30 Usual standard regimen 15 to 30 ½ the usual regimen Below 15 Use not recommended Acute Exacerbations of Chronic Bronchitis
  • Adults The usual adult dosage in the treatment of acute exacerbations of chronic bronchitis is 1 sulfamethoxazole and trimethoprim double strength tablet, or 2 sulfamethoxazole and trimethoprim single strength tablets, every 12 hours for 14 days. …
Talk to a doctor first if
  • Sulfamethoxazole and trimethoprim is contraindicated in patients with a known hypersensitivity to trimethoprim or sulfonamides, in patients with a history of drug-induced immune thrombocytopenia with use of trimethoprim and/or sulfonamides, and in patients with documented megaloblastic anemia due to folate deficiency
  • Sulfamethoxazole and trimethoprim is contraindicated
  • Pediatric patients less than 2 months of age. …
Warnings

Embryofetal Toxicity Some epidemiologic studies suggest that exposure to sulfamethoxazole/trimethoprim during pregnancy may be associated with an increased risk of congenital malformations, particularly neural tube defects, cardiovascular malformations, urinary tract defects, oral clefts, and club foot. If sulfamethoxazole/trimethoprim is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be advised of the potential hazards to the fetus. …

Possible side effects

The most common adverse effects are gastrointestinal disturbances (nausea, vomiting, anorexia) and allergic skin reactions (such as rash and urticaria). FATALITIES ASSOCIATED WITH THE ADMINISTRATION OF SULFONAMIDES, ALTHOUGH RARE, HAVE OCCURRED DUE TO SEVERE REACTIONS, INCLUDING STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, FULMINANT HEPATIC NECROSIS, AGRANULOCYTOSIS, APLASTIC ANEMIA AND OTHER BLOOD DYSCRASIAS (SEE WARNINGS SECTION). Hematologic : Agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, neutropenia, hemolytic anemia, megaloblastic anemia, hypoprothrombinemia, methemoglobinemia, eosinophilia. …

If you take too much

Acute: The amount of a single dose of sulfamethoxazole and trimethoprim that is either associated with symptoms of overdosage or is likely to be life-threatening has not been reported. Signs and symptoms of overdosage reported with sulfonamides include anorexia, colic, nausea, vomiting, dizziness, headache, drowsiness and unconsciousness. Pyrexia, hematuria and crystalluria may be noted. Blood dyscrasias and jaundice are potential late manifestations of overdosage. …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2022-10-09.

Label for sulfamethoxazole and trimethoprim, the active ingredient registered with NAFDAC.

Check your pack of Emtrim Dispersible Tablet

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC · WHO · U.S. FDA · Health Canada · NLM

About Emtrim Dispersible Tablet

What is in Emtrim Dispersible Tablet?

Emtrim Dispersible Tablet contains Sulfamethoxazole; Trimethoprim (100 mg; 20 mg), as dispersible tablet, according to its NAFDAC registration record.

Is Emtrim Dispersible Tablet registered with NAFDAC?

Yes. Emtrim Dispersible Tablet is listed on the NAFDAC register under registration number B4-3242, and its registration is active as of 28 October 2026.

Has Emtrim Dispersible Tablet been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Emtrim Dispersible Tablet in our automatically synced alert list.

How can I check that my pack of Emtrim Dispersible Tablet is genuine?

Run a free authenticity scan with the NAFDAC number B4-3242, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Emtrim Dispersible Tablet?

Follow your prescription or the leaflet in your pack. The official label says: Sulfamethoxazole and trimethoprim tablets are contraindicated in pediatric patients less than 2 months of age. Urinary Tract Infections and Shigellosis in Adults and Pediatric Patients, and Acute Otitis Media in Children Adults: The usual adult dosage in the treatment of urinary tract infections is 1 sulfamethoxazole and trimethoprim DS (double strength) tablet or 2 sulfamethox…

What is Emtrim Dispersible Tablet used for?

To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should (Summarised from the official U.S. FDA label for sulfamethoxazole and trimethoprim. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Emtrim Dispersible Tablet? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.